Edition:
United Kingdom

People: Chiasma Inc (CHMA.OQ)

CHMA.OQ on NASDAQ Stock Exchange Global Select Market

5.04USD
3:43pm BST
Change (% chg)

$0.16 (+3.28%)
Prev Close
$4.88
Open
$4.95
Day's High
$5.06
Day's Low
$4.95
Volume
14,233
Avg. Vol
172,782
52-wk High
$9.23
52-wk Low
$2.05

Ludlam, William 

Dr. William Ludlam, M.D., Ph. D. is Senior Vice President, Clinical Development and Medical Affairs of the company. And has served the Company in roles of increasing responsibility since August 2015. Prior to joining us, he served in various roles culminating in the position of Senior Medical Director of Novartis AG (NYSE: NVS), a multinational pharmaceutical company, from March 2012 to August 2015. Dr. Ludlam also founded and served as Medical Director of the Seattle Pituitary Center at the Swedish Medical Center and the Pituitary Unit at the Oregon Health & Sciences University in Portland, Oregon. Dr. Ludlam received his M.D. and Ph.D. (Developmental Neuroscience) from the Albert Einstein College of Medicine of Yeshiva University in 1995, and a B.S. in Chemistry from Whittier College in 1986.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --